Inura Medical becomes a member of Hemex Incubator
Joining Hemex Incubator, located in Liestal, Switzerland, is an important step for Inura Medical on its path towards growth and success.
Hemex Incubator offers start-ups a wealth of resources and support to help them grow their business.
By selecting Hemex Incubator with extensive in-house expertise and significant exposure to potential investors and other industry players, Inura Medical will continue developing a solution for OAB while benefiting of the networking, mentoring, and workshops supplied by Hemex.
Inura Medical AG (“Inura”) is a Swiss start-up company with a clear vision to make a difference in women’s health. Inura’s product is an innovative, first-of-a-kind “urethral ovulum” that utilizes a novel route of drug administration to treat diseases of the bladder and lower urinary tract. Inura’s technology results from decades of work in urology by Professor Grant S. Mulholland, a renowned surgeon, academic, and past President of the American Urology Association. The first indication we are addressing with the ovulum is a chronic disease, named overactive bladder (OAB). More details on https://inuramedical.ch/.
HEMEX AG is a privately-owned Swiss investment and consulting company headquartered close to the Basel global life sciences hub. Its primary focus is to bring innovative drugs, medical devices, and in–vitro diagnostics to the market. HEMEX specializes in supporting early-stage start-ups, offering tailored solutions to accelerate projects into successful and sustainable businesses. Additionally, HEMEX helps and supports start-ups to find non-dilutive and dilutive funding. More at HEMEX.